Abstract
Self-assembly of the 40/42 amino acid Aβ peptide is a key player in Alzheimers disease. Aβ40 is the most prevalent species, while Aβ42 is the most toxic. It has been suggested that the amino acids 21-30 could nucleate the folding of Aβ monomer and a bent in this region could be the rate-limiting step in Aβ fibril formation. In this study, we review our current understanding of the computer-predicted conformations of amino acids 23-28 in the monomer of Aβ(21-30) and the monomers Aβ40 and Aβ42. On the basis of new simulations on dimers of full-length Aβ, we propose that the ratelimiting step involves the formation of a multimeric β-sheet spanning the central hydrophobic core (residues 17-21).
Keywords: Protein aggregation, simulations, Amyloid-beta, Alzheimer, coarse-grained model, structures, thermodynamics, monomer and dimer
Current Alzheimer Research
Title: Role of the Region 23-28 in Aβ Fibril Formation: Insights from Simulations of the Monomers and Dimers of Alzheimers Peptides Aβ40 and Aβ42
Volume: 5 Issue: 3
Author(s): Adrien Melquiond, Xiao Dong, Normand Mousseau and Philippe Derreumaux
Affiliation:
Keywords: Protein aggregation, simulations, Amyloid-beta, Alzheimer, coarse-grained model, structures, thermodynamics, monomer and dimer
Abstract: Self-assembly of the 40/42 amino acid Aβ peptide is a key player in Alzheimers disease. Aβ40 is the most prevalent species, while Aβ42 is the most toxic. It has been suggested that the amino acids 21-30 could nucleate the folding of Aβ monomer and a bent in this region could be the rate-limiting step in Aβ fibril formation. In this study, we review our current understanding of the computer-predicted conformations of amino acids 23-28 in the monomer of Aβ(21-30) and the monomers Aβ40 and Aβ42. On the basis of new simulations on dimers of full-length Aβ, we propose that the ratelimiting step involves the formation of a multimeric β-sheet spanning the central hydrophobic core (residues 17-21).
Export Options
About this article
Cite this article as:
Melquiond Adrien, Dong Xiao, Mousseau Normand and Derreumaux Philippe, Role of the Region 23-28 in Aβ Fibril Formation: Insights from Simulations of the Monomers and Dimers of Alzheimers Peptides Aβ40 and Aβ42, Current Alzheimer Research 2008; 5 (3) . https://dx.doi.org/10.2174/156720508784533330
DOI https://dx.doi.org/10.2174/156720508784533330 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Dipeptidyl Peptidase IV Inhibitors: The Next Generation of New Promising Therapies for the Management of Type 2 Diabetes
Current Topics in Medicinal Chemistry Anthocyanins: Plant Pigments, Food Ingredients or Therapeutic Agents for the CNS? A Mini-Review Focused on Clinical Trials
Current Pharmaceutical Design Multiple Hormonal Dysregulation as Determinant of Low Physical Performance and Mobility in Older Persons
Current Pharmaceutical Design Grinding Synthesis of Pyrazolyl-Bis Coumarinyl Methanes Using Potassium 2-Oxoimidazolidine-1,3-diide
Current Organic Synthesis Meet Our Editor-in-Chief
CNS & Neurological Disorders - Drug Targets Ag/CdS Nanocomposite: An Efficient Recyclable Catalyst for the Synthesis of Novel 8-Aryl-8H-[1,3]dioxolo[4,5-g]chromene-6-carboxylic Acids under Mild Reaction Conditions
Combinatorial Chemistry & High Throughput Screening Systemic Approach to the Study of Complex Bone Disorders at the Whole- Genome Level
Current Genomics Clopidogrel Generic Formulations in the Era of New Antiplatelets: A Systematic Review
Current Vascular Pharmacology Alzheimer’s Disease Targeted Nano-Based Drug Delivery Systems
Current Drug Targets Hypericin - The Facts About a Controversial Agent
Current Pharmaceutical Design Therapeutic Advancement in Alzheimer Disease: New Hopes on the Horizon?
CNS & Neurological Disorders - Drug Targets Green Tea Extract-Patents and Diversity of Uses
Recent Patents on Food, Nutrition & Agriculture Synthesis of Polymer-Embedded Metal, Semimetal, or Sulfide Clusters by Thermolysis of Mercaptide Molecules Dissolved in Polymers
Recent Patents on Materials Science Patent Annotations
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Safeguarding Childrens Rights in Psychopharmacological Research: Ethical and Legal Issues
Current Pharmaceutical Design Meet Our Editorial Board Member
CNS & Neurological Disorders - Drug Targets A Highly Efficient Liquid Chromatography Method for the Determination of Synthetic Cannabinoid 5F-PB-22 in Mice Plasma at Nano- Concentration Range: Application to Pharmacokinetic Study
Current Analytical Chemistry Decreased Platelet APP Isoform Ratios in Autosomal Dominant Alzheimer’s Disease: Baseline Data from a DIAN Cohort Subset
Current Alzheimer Research An Improved Process for the Production of Rivastigmine Tartrate, a Cholinesterase Inhibitor
Letters in Organic Chemistry Fibrinogen Signal Transduction as a Mediator and Therapeutic Target in Inflammation:Lessons from Multiple Sclerosis
Current Medicinal Chemistry